The cannabis rescheduling hearing your clients have been asking about for a year wrapped up on July 15. If you're telling them a decision is coming this fall, you're stating an assumption as if it were a fact.
What Actually Happened at the Hearing
The DEA's multi-day hearing on cannabis rescheduling began in late June and concluded on Wednesday, July 16, 2026. The hearing concluded following closing testimony from a group of states opposing the rescheduling. DEA Chief Administrative Law Judge Derek Julius then issued an order setting the process for what comes next, described below.
During the hearing, DEA officials defending the rescheduling proposal highlighted testimony from an FDA scientist and a New Hampshire physician on marijuana's medical benefits and its relative safety compared to alcohol and opioids. Opposing parties, including Smart Approaches to Marijuana, the National Drug & Alcohol Screening Association, the Tennessee Bureau of Investigation, DUID Victim Voices, two individual witnesses, and the states of Idaho, Indiana, and Nebraska, focused on alleged harms of cannabis use and criticized the government's methodology for assessing medical value.
Here is the nuance your clients may not have seen in the headlines: DEA Administrator Terrance Cole invited only rescheduling opponents to participate as designated outside parties, telling reform-side and industry groups they did not qualify as "interested persons... adversely affected." Independent supporters were excluded from testifying, the proceeding was not livestreamed despite officials' stated commitment to transparency, and excluded advocates held a press conference describing themselves as "shut out." So this was not a two-sided industry hearing. It was DEA's own witnesses, arguing the pro-rescheduling case, against a slate of invited opponents. That distinction is worth raising with any client who asks how contestable the eventual outcome might be.
What Happens Next, and When
Post-hearing briefs, capped at 50 pages and non-mandatory, are due August 17. Proposed corrections to the hearing transcript are due the same date. After that, Judge Julius will write a recommendation on whether the government should move forward with broader rescheduling. He explicitly did not lay out a timeline for that recommendation, and the DEA Administrator, who makes the final call, has given no timeline either.
Separately, the rescheduling process, both the medical cannabis reclassification that already took effect in April 2026 and the pending broader action, is being challenged in consolidated litigation before a federal appeals court, brought by state attorneys general, cannabis legalization opponents, and at least one cannabis-focused biopharmaceutical company. That litigation is a live variable independent of the DEA's own internal timeline.
No party inside this process, not the judge, not the DEA, not Treasury, has put a date on a final ruling. Advising a client around a "fall decision" is advising them around a guess, and a guess that could just as easily land in 2027 as this year.
What This Means for How You Advise Clients Right Now
Don't defer captive formation, insurance restructuring, or entity-level 280E planning until "after rescheduling." The timeline for a final decision is genuinely open-ended. Clients who wait lose a year or more of avoidable cost with nothing gained in exchange.
Medical-only clients already got a partial answer back in April. Treasury and the IRS said rescheduling "generally removes section 280E as a bar" for activities that no longer involve a Schedule I or II substance, effective for the tax year covering the April 2026 order, though full implementing guidance on how mixed-license operators apportion expenses has not been issued. That's worth revisiting with clients now, independent of whatever the DEA Administrator eventually decides on adult-use.
Insurance and captive structure decisions do not need to wait on the scheduling question at all. The commercial cannabis insurance market is constrained by federal scheduling generally, not by the specific line between Schedule I and Schedule III, and a captive addresses that regardless of which way the eventual ruling lands.
Where This Intersects With Your Practice
Attorneys structuring MSO agreements, handling licensing compliance, or advising on entity formation are already building the legal architecture cannabis operators run inside. Captive insurance formation belongs in that architecture as a parallel workstream, not a line item to revisit once Washington finishes deciding.
3F Captive Services works with cannabis attorneys and their clients to identify the coverage and cost gaps a standard commercial policy leaves open, and to model what a captive structure could address for a specific operation.
Contact 3F Captive Services for a no-cost policy analysis for your cannabis clients. We identify the coverage gaps in their current program and model what a captive could change, regardless of where the rescheduling process stands.
⚠ This post is for informational purposes only and does not constitute insurance, legal, or tax advice. Federal rescheduling status, litigation outcomes, and captive feasibility vary by operation and jurisdiction. Consult qualified legal, tax, and insurance advisors regarding any specific matter.
Sources
[1] Marijuana Moment. "Federal Marijuana Rescheduling Hearing Wraps Up, With DEA Judge Laying Out Next Steps." July 16, 2026. https://www.marijuanamoment.net/federal-marijuana-rescheduling-hearing-wraps-up-with-dea-judge-laying-out-next-steps/
[2] Marijuana Moment. "DEA Picks Participants For Marijuana Rescheduling Hearing This Month, And Only Opponents Are Invited." https://www.marijuanamoment.net/dea-picks-participants-for-marijuana-rescheduling-hearing-this-month-and-only-opponents-are-invited/
[3] Marijuana Moment. "Inside The DEA's Marijuana Rescheduling Hearing: What I Saw, Who Was Missing And Why It Matters (Op-Ed)."https://www.marijuanamoment.net/inside-the-deas-marijuana-rescheduling-hearing-what-i-saw-who-was-missing-and-why-it-matters-op-ed/
[4] Marijuana Moment. "Feds Announce Marijuana Industry Tax Guidance Is Coming As Rescheduling Takes Effect." April 23, 2026. https://www.marijuanamoment.net/feds-announce-marijuana-industry-tax-guidance-is-coming-as-rescheduling-takes-effect/
Discover Tailored Insurance Solutions
Unlock the potential of customized captive insurance designed specifically for your unique business needs.